NYSE MKT
MYO

Myomo Inc

Medical Devices
Healthcare

Prices are adjusted according to historical splits.

Myomo Inc Stock Price

Vitals

Today's Low:
$1.13
Today's High:
$1.43
Open Price:
$1.15
52W Low:
$0.369
52W High:
$1.81
Prev. Close:
$1.12
Volume:
2659137

Company Statistics

Market Cap.:
$29.70 million
Book Value:
0.418
Revenue TTM:
$17.41 million
Operating Margin TTM:
-50.6%
Gross Profit TTM:
$10.25 million
Profit Margin:
-49.7%
Return on Assets TTM:
-39.54%
Return on Equity TTM:
-90.32%

Company Profile

Myomo Inc had its IPO on 2017-06-12 under the ticker symbol MYO.

The company operates in the Healthcare sector and Medical Devices industry. Myomo Inc has a staff strength of 100 employees.

Stock update

Shares of Myomo Inc opened at $1.15 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.13 - $1.43, and closed at $1.24.

This is a +10.71% increase from the previous day's closing price.

A total volume of 2,659,137 shares were traded at the close of the day’s session.

In the last one week, shares of Myomo Inc have increased by +45.88%.

Myomo Inc's Key Ratios

Myomo Inc has a market cap of $29.70 million, indicating a price to book ratio of 0.4805 and a price to sales ratio of 0.2714.

In the last 12-months Myomo Inc’s revenue was $17.41 million with a gross profit of $10.25 million and an EBITDA of $-8612869. The EBITDA ratio measures Myomo Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Myomo Inc’s operating margin was -50.6% while its return on assets stood at -39.54% with a return of equity of -90.32%.

In Q2, Myomo Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 62%.

Myomo Inc’s PE and PEG Ratio

Forward PE
0
Trailing PE
0
PEG
0

Its diluted EPS in the last 12-months stands at $-0.88 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Myomo Inc’s profitability.

Myomo Inc stock is trading at a EV to sales ratio of 0.0077 and a EV to EBITDA ratio of 0.282. Its price to sales ratio in the trailing 12-months stood at 0.2714.

Myomo Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$13.30 million
Total Liabilities
$4.34 million
Operating Cash Flow
$-3008690.00
Capital Expenditure
$14973
Dividend Payout Ratio
0%

Myomo Inc ended 2024 with $13.30 million in total assets and $0 in total liabilities. Its intangible assets were valued at $13.30 million while shareholder equity stood at $8.82 million.

Myomo Inc ended 2024 with $0 in deferred long-term liabilities, $4.34 million in other current liabilities, 2110.00 in common stock, $-92441689.00 in retained earnings and $0 in goodwill. Its cash balance stood at $6.01 million and cash and short-term investments were $8.96 million. The company’s total short-term debt was $181,783 while long-term debt stood at $0.

Myomo Inc’s total current assets stands at $12.63 million while long-term investments were $102773.00 and short-term investments were $2.95 million. Its net receivables were $1.64 million compared to accounts payable of $766583.00 and inventory worth $1.34 million.

In 2024, Myomo Inc's operating cash flow was $-3008690.00 while its capital expenditure stood at $14973.

Comparatively, Myomo Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price
$1.24
52-Week High
$1.81
52-Week Low
$0.369
Analyst Target Price
$3.31

Myomo Inc stock is currently trading at $1.24 per share. It touched a 52-week high of $1.81 and a 52-week low of $1.81. Analysts tracking the stock have a 12-month average target price of $3.31.

Its 50-day moving average was $0.76 and 200-day moving average was $0.61 The short ratio stood at 0.09 indicating a short percent outstanding of 0%.

Around 1772.3% of the company’s stock are held by insiders while 1769.7% are held by institutions.

Frequently Asked Questions About Myomo Inc

The stock symbol (also called stock or share ticker) of Myomo Inc is MYO

The IPO of Myomo Inc took place on 2017-06-12

Similar Industry Stocks (Medical Devices)

Last Price
Chg
Chg%
$1.34
-0.11
-7.59%
$810.05
-14.65
-1.78%
Innospec Inc (IOSP)
$106.51
1.84
+1.76%
ZTE Corp-H (ZTCOF)
$3.04
0.06
+2.01%
Voltas Limited (VOLTAS)
$875.55
-31.65
-3.49%
$68.84
-1.97
-2.78%
$437
-13.85
-3.07%
$33.91
-0.23
-0.67%
$46.47
-0.15
-0.32%
$50.52
0.67
+1.34%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Address

137 Portland Street, Boston, MA, United States, 02114